Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 110 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34 | -30.6% | 6,302 | -13.9% | 0.00% | – |
| Q2 2023 | $49 | -79.3% | 7,317 | -84.6% | 0.00% | – |
| Q1 2023 | $237 | +393.8% | 47,409 | +380.9% | 0.00% | – |
| Q4 2022 | $48 | -100.0% | 9,859 | -84.7% | 0.00% | -100.0% |
| Q3 2022 | $929,000 | +2060.5% | 64,445 | +2192.6% | 0.00% | – |
| Q2 2022 | $43,000 | -36.8% | 2,811 | -51.5% | 0.00% | – |
| Q1 2022 | $68,000 | -96.5% | 5,795 | -95.2% | 0.00% | – |
| Q4 2021 | $1,944,000 | +290.4% | 119,956 | +586.7% | 0.00% | – |
| Q3 2021 | $498,000 | +114.7% | 17,469 | +154.9% | 0.00% | – |
| Q2 2021 | $232,000 | -77.4% | 6,854 | -79.8% | 0.00% | -100.0% |
| Q1 2021 | $1,028,000 | +70.8% | 34,001 | +180.0% | 0.00% | – |
| Q4 2020 | $602,000 | -67.7% | 12,144 | -75.0% | 0.00% | -100.0% |
| Q3 2020 | $1,865,000 | -17.0% | 48,555 | -6.6% | 0.00% | -50.0% |
| Q2 2020 | $2,247,000 | +699.6% | 52,004 | +382.4% | 0.00% | – |
| Q1 2020 | $281,000 | -68.0% | 10,781 | -61.6% | 0.00% | – |
| Q4 2019 | $878,000 | +165.3% | 28,062 | +120.9% | 0.00% | – |
| Q3 2019 | $331,000 | +10.3% | 12,701 | -3.2% | 0.00% | – |
| Q2 2019 | $300,000 | -29.6% | 13,119 | -19.3% | 0.00% | – |
| Q1 2019 | $426,000 | +102.9% | 16,252 | +57.2% | 0.00% | – |
| Q4 2018 | $210,000 | – | 10,339 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 216,916 | $6,191,000 | 3.86% |
| Sofinnova Investments, Inc. | 2,194,278 | $62,625,000 | 3.71% |
| MPM BioImpact LLC | 452,970 | $12,928,000 | 2.00% |
| Soleus Capital Management, L.P. | 265,700 | $7,583,000 | 1.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 452,110 | $12,903,000 | 1.17% |
| ORACLE INVESTMENT MANAGEMENT INC | 315,642 | $9,008,000 | 1.12% |
| First Light Asset Management, LLC | 577,663 | $16,487,000 | 1.09% |
| Lombard Odier Asset Management (Switzerland) SA | 352,839 | $10,070,000 | 0.62% |
| Cormorant Asset Management, LP | 500,000 | $14,270,000 | 0.58% |
| Artal Group S.A. | 400,000 | $11,416,000 | 0.26% |